CVS Health: targets lowered for 2024

(CercleFinance.com) - CVS Health has lowered its targets for 2024, expecting adjusted EPS of between $6.
40 and $6.65 (instead of at least $7) and cash flow from operations of around $9bn (instead of at least $10.5bn).

The healthcare group justifies this downgrade by continued pressure in its health care benefits segment, partly offset by a vigorous performance in its health services and pharmacy & consumer wellness segments.

For Q2 2024, CVS Health's adjusted EPS fell over 17% to $1.83, while its adjusted operating profit declined 16.4% to $3.74bn, on revenues that are up 2.6% to $91.2bn.


Copyright (c) 2024 CercleFinance.com. All rights reserved.